Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Lambert

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2020
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2)J L W Lambert, S Segaert, P D Ghislain, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2020
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 1)J L W Lambert, S Segaert, P D Ghislain, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 12, 2024
Belgian recommendations for managing psoriasis in a changing treatment landscapeR Speeckaert, A F Nikkels, J Lambert, et al.
The British Journal of Dermatology|February 17, 2017
Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patientsM Talamonti, M Galluzzo, J M van den Reek, et al.
The Journal of Investigative Dermatology|December 24, 2005
Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomesSofie De Schepper, Joachim M A Boucneau, Wendy Westbroek, et al.
The Journal of Investigative Dermatology|August 17, 2012
Identification of miR-145 as a key regulator of the pigmentary processPeter Dynoodt, Pieter Mestdagh, Gert Van Peer, et al.
Trials|October 17, 2021
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study-the BeNeBio studyLara S van der Schoot, Juul M P A van den Reek, Lynda Grine, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2013
Profile of the Belgian dermatologist: results of an online surveyJ L W Lambert, J André, M Boone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 21, 2026
International consensus on dose reduction of biologics for patients with psoriasis: The DR. Delphi studyC A M van Riel, W-H Boehncke, J L W Lambert, et al.
Dermatology and Therapy|December 9, 2022
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European InitiativeJan Koren, Jo L W Lambert, Simon F Thomsen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2020
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2)J L W Lambert, S Segaert, P D Ghislain, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2020
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 1)J L W Lambert, S Segaert, P D Ghislain, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 12, 2024
Belgian recommendations for managing psoriasis in a changing treatment landscapeR Speeckaert, A F Nikkels, J Lambert, et al.
The British Journal of Dermatology|February 17, 2017
Role of the HLA-C*06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patientsM Talamonti, M Galluzzo, J M van den Reek, et al.
The Journal of Investigative Dermatology|December 24, 2005
Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomesSofie De Schepper, Joachim M A Boucneau, Wendy Westbroek, et al.
The Journal of Investigative Dermatology|August 17, 2012
Identification of miR-145 as a key regulator of the pigmentary processPeter Dynoodt, Pieter Mestdagh, Gert Van Peer, et al.
Trials|October 17, 2021
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study-the BeNeBio studyLara S van der Schoot, Juul M P A van den Reek, Lynda Grine, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2013
Profile of the Belgian dermatologist: results of an online surveyJ L W Lambert, J André, M Boone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 21, 2026
International consensus on dose reduction of biologics for patients with psoriasis: The DR. Delphi studyC A M van Riel, W-H Boehncke, J L W Lambert, et al.
Dermatology and Therapy|December 9, 2022
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European InitiativeJan Koren, Jo L W Lambert, Simon F Thomsen, et al.
Pageof 3